A Study to Evaluate ICP-022 in Patients With CLL/ SLL
Clinical trial NCT03493217 · UNKNOWN
Trial details
- NCT number
- NCT03493217
- Sponsor
- Beijing InnoCare Pharma Tech Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-17
- Primary completion
- 2022-12-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.